MAPS Members, Supporters, and Friends,

The fate of MAPS’ quest to put marijuana through FDA clinical trials is in a thrilling but precarious position — the DEA’s hands. After six years of struggle since renowned agronomist Professor Lyle Craker first applied to the DEA for a Schedule I license for a MAPS-sponsored research-grade marijuana production facility, we are now just one signature away from breaking the federal government’s decades-long stranglehold on medical marijuana research. On May 15, the case was officially transmitted to DEA headquarters.

On May 16, a “Dear Colleague” letter by Reps. John Olver (D-MA) and Dana Rohrabacher (R-CA) was sent to all members of the US House of Representatives, urging each member to add their name to their Congressional Sign-On letter to DEA Administrator Karen Tandy urging the DEA to accept the recent non-binding ruling by DEA Administrative Law Judge Mary Ellen Bittner in favor of MAPS and Prof. Craker. To succeed at this critical juncture, we’ll need each supporter to contact his or her Congressional Representative (see Item #2).

Meanwhile, the MAPS staff is continuing to refine the organization’s objectives as we prepare for the next stages of our psychedelic and marijuana research agenda. MAPS has a valuable new addition to the Board of Directors (Item #9) and will be undergoing a specialized management review over the next two months (Item #10). These developments are a continuation of our larger strategy to build a thoroughly efficient, sustainable research and educational organization that will meet both its short-term and long-term goals.

MAPS has positioned itself at the center of the conflict between scientific exploration and the politically-driven strategy of the War on Drugs. Your support is needed to translate hard-won scientific freedom into new research results and possibilities.

Help bring MAPS’ challenging but realizable vision to fruition for ours and future generations by making a purchase or a charitable gift today: http://www.maps.org/catalog

There’s so much good news to report this month that the headlines are split into four sections.

MAPS & Medical Marijuana

1. Marijuana Research in the Balance: Final Legal Filings Filed, Case Transmitted to DEA Headquarters

2. Help MAPS and Marijuana Research Succeed by Contacting Your Congressional Representative

3. $12,500 Grant from Drug Policy Alliance (DPA) for MAPS’ Marijuana Research Effort

4. New Studies Show Potential of Marijuana Vaporizer Research

MAPS-Sponsored Psychedelic Research

5. FDA Will Approve MAPS-Sponsored Swiss and Israeli MDMA/PTSD studies for MAPS’ Investigational New Drug (IND) Application

6. Ongoing Swiss MDMA/PTSD Study Makes Progress

7. Dr. Mithoefer to Present on MDMA Research at International PTSD Conference

8. MAPS Preparing for Ibogaine Study in Mexico as Parallel Canadian Study Continues; Laptop Donation Needed!

Inside MAPS

9. Shawn Hailey Joins MAPS Board of Directors

10. MAPS Preparing for Professional Management Review

11. Fundraisers in San Francisco Area Raise Over $23,500 for MAPS

12. Thanks to Robert Barnhart and Anonymous Donor for $40,000 and $25,000 Donations

13. Call for Articles for Upcoming Special MAPS Bulletin

Upcoming MAPS Events

14. 3rd Amazonian Shamanism Conference: Healing Plants and Navigational Tools

15. Mind States Costa Rica: Last-Minute Tickets Available

16. Women’s Visionary Congress Tickets Sold Out

*** Your support is needed — join the force today! http://www.maps.org/catalog ***

MAPS & Medical Marijuana

1. Marijuana Research in the Balance: Final Legal Filings Filed, Case Transmitted to DEA HQ

On May May 4, Prof. Craker filed the final brief in his MAPS-sponsored DEA Administrative Law Judge case.  This brief is a strong response to the DEA’s “exceptions” to ALJ Bittner’s recommendation that it would be in the public interest for DEA to register Prof. Craker as a bulk manufacturer of research-grade marijuana for his proposed MAPS-sponsored independent production facility. It was prepared by an outstanding legal team led by Julie Carpenter, Jenner & Block, Allen Hopper, ACLU, and Emanuel Jacobowitz, Steptoe & Johnson, and assisted by Christina Alvarez, ACLU, and Lauren Payne, MAPS.

Read the “Respondent’s Response to the Government’s Exceptions to Opinion and Recommended Ruling, Findings of Fact, Conclusions of Law, and Decision of the Administrative Law Judge” at: http://www.maps.org/mmj/5.4.07_response_to_government_exceptions.pdf

On May 15, DEA Administrative Law Judge Mary Ellen Bittner transmitted the case files to DEA, officially putting the ball in the DEA’s court to decide whether to accept or reject the Judge’s non-binding ruling. Unfortunately, there is no time limit for the DEA to issue its final decision, so we are anticipating a wait of anywhere between 3 months and two years, based on previous cases.

On the morning of Wednesday, May 23, MAPS President Rick Doblin, PhD, Prof. Lyle Craker and medical marijuana patient Angel Raich will hold a brief press conference on the sidewalk outside of DEA headquarters in Washington, DC, followed by a national teleconference at 1:15 pm.

For complete background on the case, see: http://www.maps.org/mmj/DEAlawsuit.html

2. Help MAPS and Marijuana Research Succeed by Contacting Your Congressional Representative

On May 16, a “Dear Colleague” letter by Reps. John Olver (D-MA) and Dana Rohrabacher (R-CA) was sent to all members of the US House of Representatives, urging each member to sign their Congressional Sign-On Letter to DEA Administrator Karen Tandy urging the DEA to accept the recent non-binding ruling by DEA Administrative Law Judge Mary Ellen Bittner in favor of MAPS and Prof. Craker.

To succeed at this critical juncture, we’ll need each supporter to contact his or her Congressional Representative — here’s how:

To reach your Representative by phone, call the congressional switchboard at: (202) 224-3121 or (800) 962-3524.

To reach your Representative by mail, write to: The Honorable (full name)/House Office Building/United States House of Representatives/Washington DC 20515

Tell your Congressperson that you would like him or her to add his or her name to the Congressional Sign-On Letter sponsored by John Olver and Dana Rohrbacher urging the DEA to follow the DEA administrative law judge’s Recommended Ruling by granting a Schedule I license to Professor Lyle Craker, UMass-Amherst. If you feel comfortable, explain that you would like to see the controversy over medical marijuana resolved through privately-funded FDA-approved research, and that Prof. Craker’s case is the focal point of the struggle to evaluate whether medical marijuana meets the FDA’s standards for safety and efficacy.  Individualized letters and phone calls are the best ways to get the attention of your legislators. E-mails are helpful, but phone calls and especially personal letters or faxes carry significantly more weight. No matter what, always be courteous and succinct.

For complete background on the case, see: http://www.maps.org/mmj/DEAlawsuit.html

3. $12,500 Grant from Drug Policy Alliance (DPA) for MAPS’ Marijuana Research Effort

Last month, MAPS was awarded a grant of $12,500 from the Drug Policy Alliance (DPA), for our efforts to pressure DEA to accept Judge Bittner’s ruling on behalf of Prof. Craker.

DPA is the leading organization in the US working to end the war on drugs and envision new drug policies based on science, compassion, health and human rights. We are grateful to have DPA as an ally in the struggle to create rational alternatives to prohibition-based policy.

Learn more about DPA on their Web site: http://www.drugpolicy.org

4. Two New Studies Show Potential of Marijuana Vaporizer Research

Two new studies, one from University of California-San Francisco, and the other from SUNY-Albany, provide strong evidence that vaporization has promising potential as a method of medical marijuana delivery. The first study, published online by the journal Clinical Pharmacology and Therapeutics, was conducted at UCSF by a team led by Donald Abrams, MD, and  compared a commercially available vaporizer to smoking in 18 volunteers. The researchers found that, “vaporization of marijuana does not result in exposure to combustion gases, and therefore is expected to be much safer than smoking marijuana cigarettes.” Dr. Abrams was able to obtain permission from FDA to conduct his study based in part on data on the composition of the ingredients in marijuana vapor gathered in research sponsored by MAPS and CaNORML. That line of MAPS-sponsored research is currently blocked since NIDA has refused to sell marijuana for additional studies.

Dr. Abrams’ study is available online at: http://www.maps.org/media/vaporizer_epub.pdf

The second study, conducted by Mitch Earleywine, PhD, at SUNY-Albany, and published in Harm Reduction Journal, was based on an extensive survey of over 7,000 marijuana users. After adjusting for variables such as age and cigarette use, Earleywine found that vaporizer users were 60 percent less likely than smokers to report respiratory symptoms such as cough, chest tightness or phlegm, and that the effect of vaporizer use was more pronounced the larger the amount of marijuana used.

The study is available online at: http://www.harmreductionjournal.com/content/pdf/1477-7517-4-11.pdf

MAPS hopes to eventually put vaporized marijuana through FDA clinical trials, but has been stalled since June 2003 because of NIDA’s monopoly on the supply of research-grade marijuana. Research into alternative delivery methods such as vaporization was one of the primary recommendations of the Institute of Medicine’s landmark 1999 report on medical marijuana .

Marijuana vaporization is an effective delivery method because it has the rapid action and easy dose adjustment of inhalation, but without the respiratory hazards associated with smoking. Unlike smoking, a vaporizer does not burn the plant material, but heats it just to the point at which THC and cannabinoids vaporize into steam.

MAPS-Sponsored Psychedelic Research

5. FDA Approves MAPS-Sponsored Swiss and Israeli MDMA/PTSD studies for MAPS’ Investigational New Drug (IND) Application

MAPS is currently sponsoring three pilot studies evaluating MDMA-assisted psychotherapy for subjects with treatment-resistant posttraumatic stress disorder (PTSD), in the US, Switzerland, and Israel. Last month, we learned that the data being generated from the Swiss and Israeli studies will be accepted by the US FDA.

Although these protocols do not need to be approved by the FDA to be conducted in their home countries (they have already been approved by their home country’s regulatory agency equivalent to FDA and by local ethics committees), FDA review and approval enables us to submit to FDA the data from these two studies as part of MAPS’ Investigational New Drug (IND) application for MDMA-assisted psychotherapy in the treatment of PTSD. The data from these studies will be used to help negotiate with FDA regarding the design of larger Phase 3 studies intended to gather data to determine whether or not MDMA meets the requirements necessary to be approved as a legal prescription medicine.

To learn more about the MAPS-sponsored study in Israel evaluating MDMA-assisted psychotherapy for subjects with war- and terrorism-related PTSD, the protocol is posted on the MAPS Web site at: http://www.maps.org/mdma/israel_protocol_3.16.05.pdf

To learn more about the MAPS-sponsored MDMA/PTSD study in Switzerland, the protocol is posted on the MAPS Web site at: http://www.maps.org/mdma//swissmdmaptsd/protocol1608.pdf

6. Ongoing Swiss MDMA/PTSD Study Makes Progress

The ongoing MAPS-sponsored MDMA/PTSD study in Switzerland, led by Peter Oehen, MD, has completed treatment for two subjects and is currently treating the third and fourth subjects. In addition, two new subjects have qualified for the study and will begin treatment this summer.

7. Dr. Mithoefer to Present on MDMA Research at International PTSD Conference

Dr. Michael  and Annie Mithoefer, the co-therapists for MAPS’ US MDMA/PTSD study, were in Norway recently attending a workshop by Dr. Edna Foa, an internationally-recognized expert in the treatment of PTSD. The workshop was organized by Pal-Orjan Johansen, a Ph.D. candidate at the Trondheim Psychotherapy Research Program, Department of Psychology, The Norwegian University of Science and Technology, and Teri Krebs, B.S., Program in Neuroscience, Boston University.

While in Norway, Dr. Michael and Annie Mithoefer were also able to work with Pal and Teri, who are conducting a MAPS-sponsored study reviewing audio and video recordings and transcripts of subjects in the Mithoefer’s MDMA/PTSD research, in order to code and compare the psychological defense mechanisms used in both non-drug therapy sessions and in the experimental MDMA-assisted therapy sessions. This study is designed to identify process variables that may help explain how MDMA can be a useful adjunct to psychotherapy.

Dr. Michael and Annie Mithoefer were also able to discuss with Pal and Teri their MAPS-sponsored project using the internet to search for reports of people with Asperger’s (a form of high-functioning autism) who have found MDMA to be helpful in their learning to cope more effectively in social situations. If we do find at least a handful of such reports, this could become another area of research, if funding becomes available.

Drs. Mithoefer, Peter Oehen and Franz Vollenweider, will be presenting their MDMA/PTSD work at the European Conference on Traumatic Stress in Croatia next month.

Learn more about Dr. Mithoefer’s landmark MDMA/PTSD study on the MAPS Web site: http://www.maps.org/mdma/protocol/index.html

8. MAPS Preparing for Ibogaine Study in Mexico as Parallel Canadian Study Continues; Laptop Donation Needed!

The Iboga Therapy House is now enrolling clients in MAPS’ IRB-approved long-term observational case study. Three subjects have been enrolled in the  study so far and will be followed up on a monthly basis for a full year after their initial ibogaine treatment.  The study will examine changes in substance use in 20 consecutive individuals undergoing ibogaine-based addiction treatment for opiate dependence at the Iboga Therapy House near Vancouver, Canada.

Learn more about the Iboga Therapy House at: http://www.ibogatherapyhouse.net

Meanwhile, MAPS is currently developing the protocol for a parallel MAPS-sponsored observational case study in Mexico under the direction of Principal Investigator John Harrison, PsyD (cand). The study would evaluate changes in substance use in 20 consecutive individuals undergoing ibogaine-based addiction treatment for opiate dependence at Mexico’s Ibogaine Association. The Ibogaine Association has been under new management since 2006, and has significantly upgraded the quality of services for its clients.

Learn more about the Ibogaine Association at: http://www.ibogaine-therapy.net/

While on that note, we are looking for a laptop donation! We’re seeking a functional laptop less than three years old for the proposed MAPS-sponsored study in Mexico. It will be used primarily for email, word processing, and internet and can be either Windows or Macintosh. We don’t mind reinstalling the OS, upgrading RAM, and doing other light upgrades and maintenance to make it functional. Please write to josh@maps.org if you have a machine that you would like to donate.

Inside MAPS

9. Shawn Hailey Joins MAPS Board of Directors

We’re pleased to announce that longtime MAPS supporter Shawn Hailey is joining the MAPS Board of Directors as the fourth member.

Shawn will actively work with MAPS President Rick Doblin, PhD, and the other members of the Board of Directors to strengthen the organization, both by reviewing business and technical proposals, and by helping MAPS refine its long-term vision. We’re looking forward to Shawn’s increased input as we focus on meeting the challenges of success at this critical phase in the organization’s development.

Shawn and his twin brother, Kim, worked for almost 2 decades to build a software company focused on computer chip design and manufacture, before taking their company public. As a result, Shawn has extensive experience in managing growth and offers that experience to MAPS as we enter our own growth phase. For a fascinating, though somewhat technical, 1997 interview with Shawn and Kim about the history of their company, Meta-Software, see: http://silicongenesis.stanford.edu/transcripts/hailey.htm

10. MAPS Preparing for Professional Management Review Process

Over the months ahead, the MAPS staff will be participating in a management review project with The Management Center, a nonprofit that helps progressive advocacy organizations get results in pursuit of their missions. The Management Center is funded by philanthropist Peter Lewis to provide professional management assistance to the organizations to which he contributes. The MAPS staff is very thankful to Peter for this fantastic opportunity.

11. Fundraisers in San Francisco Area Raise Over $23,500 for MAPS

Our fundraising events last month were a major success. On Friday, April 27, we held an intimate “meeting of the minds” with 15 distinguished psychedelic guests over an 8-course meal at the home of MAPS patron member Richard Miller in Tiburon, CA. On Saturday night, April 28, we held an all-night party with a spectacular line-up of guest speakers, DJs and visual artists at the home of MAPS patron member Richard Wolfe in San Francisco. Together the two events brought in over $30,000 with a profit of nearly $24,000 after costs. Special thanks to False Profit < http://www.false-profit.com/> and DogStar Catering < http://www.dogstarcatering.com/> for their collaboration with MAPS on these two events — and an extra special thanks to everyone who came out to support the psychedelic community! Watch the MAPS email news update for an announcement about our next San Francisco area event, tentatively scheduled for this fall in an historical psychedelic Victorian mansion in the Haight-Ashbury district.

12. Special Thanks to Robert Barnhart and Anonymous Donor for $40,000 and $25,000 Donations

MAPS is deeply grateful to longtime MAPS supporter Robert Barnhart for making a $40,000 charitable gift to MAPS in the last month. In addition, MAPS also received a $25,000 donation from an anonymous donor.

13. Call for Articles for Upcoming Special MAPS Bulletin

For the following MAPS Bulletin, we’re getting down to basics in a special theme issue. And we want to hear from YOU.

Have psychedelics been important to your personal development? How so?

Please share your stories with us for the upcoming special edition of the MAPS Bulletin, “Psychedelics & Self-Discovery.”

We are looking for articles that are between 400-1500 words. Articles may be submitted anonymously if that makes you more comfortable (although, all things being equal, we do prefer for people to write under their “real” names when possible). If possible, please send a high-quality photo of yourself to go with the article. Please send your submission to Sarah Hufford by June 22.

Upcoming MAPS Events

14. 3rd Amazonian Shamanism Conference: Healing Plants and Navigational Tools

“The Third Annual Amazonian Shamanism Conference: Healing Plants and Navigational Tools” will take place once again in Iquitos, Peru, from July 7-14. Shamans, curanderos, scientists, and psychonauts will gather for lectures, discussions, and experiential workshops. Special guests will include Dennis McKenna, Peter Gorman, Alan Shoemaker, Richard Grossman, Jimmy Weiskopf, Kevin Furnas, and many more. Traditional healers will also give presentations and participate in panel discussions.

Conference Web Site: http://soga-del-alma.org/ConferenceSite

15. Mind States Costa Rica: Last-Minute Tickets Available

The upcoming Mind States seminar will be held June 13-17 in Costa Rica. To purchase tickets or check out the latest developments, visit
http://www.mindstates.org

16. Women’s Visionary Congress Tickets Sold Out

Tickets have sold out for this summer’s Women’s Visionary Congress: Consciousness, Healing, and Social Justice, at Wilbur Hot Springs in Calousa county, California. For complete information go to: http://www.visionarycongress.org

***************

Now that our applications to conduct psychedelic research are finally being granted, the biggest thing limiting progress is no longer the government. It is our ability to fund the research and the work that goes into it.

The future is in our hand
s. Throw your weight behind MAPS’ work today:
http://www.maps.org/catalog

Thank you.

Best Wishes,
Jag

Miracle Grow worked for me the first year
BudBurner
May 15th 2007

In the early nineties cannabis cultivation had dramatically changed,
indoor hydroponics chemical grown cannabis was now readily on the
market, many mature cannabis users complained that the hydro grown
cannabis, made them feel quite ill the next morning, others maintained
hydroponicly grown cannabis caused a form of psychosis, this being
due to the amount of chemicals used when growing indoors. Yes, a
public health hazard

Prohibition has created a health risk to many Victorians, as organic
grown cannabis is now only a small part of the commercial market,
hydroponicly grown chemically enhanced adulterated cannabis holds the
major share of the market. Unfortunately, the younger generation of
cannabis consumers know no little difference between the two, as
organic cannabis is now a thing of the past.

Hydroponics is just a culture method. Hydroponics can be
done either with chemical or organic fertilizers, such as
worm pee. Also, chemical plant foods such as Miracle-Gro
work poorly with hydroponics but (I know everyone’s gonna
flame me) quite well with soil.

Well, Miracle Grow worked for me the first year I grew. I
know many growers who use it; if it is withheld at the opportune time
before the harvest the bud will taste and smoke quite well. I have a
grower neighbor that uses Miracle Grow’s Muracid to charge the soil
media with a big blast of nitrogen and acidify the soil, the rest of
the time he uses commercial tomato fertilizer. His herb seems a bit
harsh but I think he doesn’t let it cure long enough; his buds are a-
burning before the plant has even realized it’s hanging upside down.
I use organics such as bat shit because I like the way
organics seem to bring out the earthy flavor so lacking in hydroponic
media. Even organic hydroponics don’t seem to match the flavors from
soil organics.
BudBurner


Student activists are accusing University Police of violating students’ privacy with overly aggressive drug enforcement tactics in the wake of several incidents in which officers posed as students or drug dealers.

Undercover officers frequently patrol hallways in dorms searching for would-be narcotics buyers, University Police spokeswoman Maj. Cathy Atwell said. But the activist group Students for Sensible Drug Policy said police crossed the line when an officer attempted to join their Facebook group under an assumed name. The students discovered the officer when they cross-referenced her e-mail address in the university directory.

Atwell said she did not know of the Facebook incident SSDP mentioned, but she defended officers’ approach to busting students for drugs in student housing.

“This has always been a tactic that we’ve used,” she said, noting that drug enforcement is a particular priority for University Police because drug use often leads to other types of crime. “Our police are committed to upholding the drug and alcohol policy. … What’s unreasonable about upholding the law?”

Why would the police want to give up nice, safe and easy drug busts? They might be forced to fight crimes that have victims.

Police infiltrating organizations is a great political tactic. It is a barrier to building trust between members. After all, if narcs infiltrate student organizations, they are capable of infiltrating any organization. For all that I know, narcs have infiltrated the Saskatchewan Marijuana Party. Maybe the president is a dirty narc, ready and willing to report us if we dare pass joints around. I heard that he doesn’t even smoke marijuana. How can we trust him? Infighting and a lack of trust can be a real barrier to achieving the goals and aims of activist organizations. If members of Students for Sensible Drug Policy are busy pointing fingers and trying to figure out who the narc is, they will have a much more difficult time raising money, printing and handing out flyers, organizing rallies, blogging or writing letters to the editor. Militant drug legalizers will be less effective. Divide and conquer!

I wonder if Martin Luther King or Ghandi had to deal with narcs.


Study: Alcohol, Tobacco Worse Than Drugs Study:

Alcohol and Tobacco More Dangerous Than Some Illegal Drugs Like Marijuana or Ecstasy By MARIA CHENG The Associated Press

LONDON - New “landmark” research finds that alcohol and tobacco are more dangerous than some illegal drugs like marijuana or Ecstasy and should be classified as such in legal systems, according to a new British study.

In research published Friday in The Lancet magazine, Professor David Nutt of Britain’s Bristol University and colleagues proposed a new framework for the classification of harmful substances, based on the actual risks posed to society. Their ranking listed alcohol and tobacco among the top 10 most dangerous substances.

Nutt and colleagues used three factors to determine the harm associated with any drug: the physical harm to the user, the drug’s potential for addiction, and the impact on society of drug use. The researchers asked two groups of experts psychiatrists specializing in addiction and legal or police officials with scientific or medical expertise to assign scores to 20 different drugs, including heroin, cocaine, Ecstasy, amphetamines, and LSD.

Nutt and his colleagues then calculated the drugs’ overall rankings. In the end, the experts agreed with each other but not with the existing British classification of dangerous substances.

Heroin and cocaine were ranked most dangerous, followed by barbiturates and street methadone. Alcohol was the fifth-most harmful drug and tobacco the ninth most harmful. Cannabis came in 11th, and near the bottom of the list was Ecstasy.

According to existing British and U.S. drug policy, alcohol and tobacco are legal, while cannabis and Ecstasy are both illegal. Previous reports, including a study from a parliamentary committee last year, have questioned the scientific rationale for Britain’s drug classification system.

Along with our weekly in-depth Chronicle reporting, DRCNet has since late summer also been providing daily content in the way of blogging in the Stop the Drug War Speakeasy, as well as Latest News links (upper right-hand corner of most web pages), event listings (lower right-hand corner) and other info. Check out DRCNet every day to stay on top of the drug reform game!

Chronicle editor Phil Smith was traveling most of this week, and so most of this week’s blogging was done by content editor Scott Morgan. Scott contributed “ONDCP Admits Exaggerating Marijuana Potency,” “Wanna Beat a Drug Test? Switch From Pot to Oxycodone,” and “False Positives: The Dark Secret of the Drug Testing Regime.”Also joining us this week was Univ. of Las Vegas professor Randall Shelden, who contributed “Review of Lies, Damned Lies and Drug War Statistics by Matt B. Robinson and Renee G. Scherlen (SUNY Press, 2007).”

Check them out at http://stopthedrugwar.org/speakeasy — we encourage you to post comments.

Also check out our “In the Trenches” activist feed for a plethora of press releases, action alerts, job listings and other interesting items reposted from many allied organizations around the world. And please join our Reader Blogs where you can become an author in the DRCNet community too.

A report published by the Lancet on the Development of a rational scale to assess the harm of drugs of potential misuse calls for the UK government to change the way that it classifies drugs. Currently the UK government, the UN and many major industrialised countries have drug classification systems that are supposed to be based upon the risks and harms associated with each drug. However, the report claims that the methodology behind the current classification systems is flawed and there is no satisfactory correlation between the harm the drugs cause and the ranking by which they are classified.

The report found that alcohol and tobacco, both currently legal drugs in the UK, fall into a category of risk and potential harm that is ranked only a little below that of heroin and cocaine. Whereas drugs such as ecstasy and LSD are illegal and pose less risk of harm.

The report states that the methodology determining the current classification system is “ill defined, opaque and arbitrary” This is due to a variety of reasons such as the complexity of factors necessary to assess the harm of drugs and the lack of evidence available. There is therefore a necessity to establish a new system of determining harm based more fact and scientific knowledge.

This idea that the current system of assessment is flawed supports ideas discussed in Richard Fielding’s lecture where we determined that perception plays a role in the determination of risk. In his lecture he quoted Mary Douglas stating “the effect of culture is to focus attention on certain dangers thereby transforming them into moral indicators” i.e. that the risk is not just a physical danger but rather a moral one. The report states that ‘discussions based upon formal assessment of harm  rather than the prejudice and assumptions may help society to engage in a more rational debate about the relative risk of harm of drugs’ Also the report noted that ‘it surely must be worth considering that two most widely lie in the upper half of the rankings of harm and that it is necessary for this to be taken into account when discussing misuse of drugs’

Heroin on the NHS - Cannabis back to Class B?
Dailyreferendum.blogspot.com
April 19th 2007

The Problem

The UK Drug Policy Commission has issued a report stating that the UK has the highest level of drug use and the second highest number of drug-related deaths in Europe . Drug addiction rates in the UK are double those in France, Sweden, Germany and the Netherlands.

The UK illegal drugs market is worth about £5bn/year, drug-related crime is estimated at more than £13bn. About one in five people arrested is a heroin addict. There has been a 111% rise in drug-related offences between 1994 and 2005. This is not surprising when you consider that the heroin street price has dropped, falling from £70 a gram in 2000 to £54 in 2005.

The Commission said: “Tougher enforcement should theoretically make illegal drugs more expensive and harder to get. The prices of the principal drugs in Britain have declined for most of the last 10 years and there is no indication that tougher enforcement has succeeded in making drugs less accessible.”

More addicts are being treated than ever before, but the UK Drug Policy Commission said that: “the benefits were limited, and there was little evidence education schemes had had an impact.” More…..

Pot Politics, Marijuana Myths, and Cannabis Culture
Associatedcontent.com
April 18th 2007

First things first: For those of you who have no idea who William Randolf Hearst, Andrew Mellow, or Harry J. Anslinger were, do a google search including ‘marijuana’ or ‘hemp’. The simple fact of the matter is, most people are ignorant of the facts behind Marijuana prohibition. Unlike alcohol’s one hundred thousand or big tobacco’s more than four hundred thousand killed a year, Cannabis Sativa Indica Ruderalis also known as Hemp or Marijuana, has killed no one.
Apart from the fact that more people go to jail for marijuana than for violent crime, you’d think that the government was on to something. You’d think that, because more than five hundred thousand people a year die from using marijuana, the government would have to do something about it. You’d probably think that going to prison for five years or more as a minimum would be great for the drug pushers dealing in such a dangerous drug, and you’d be right.
As least as far as MADD, SADD, DADD, and tobacco activists might be concerned. But the fact of the matter is, marijuana is more beneficial than crude oil, provides more protein than soy beans, and has more versatility than both combined. Acre for acre, it provides more paper of a higher quality than any tree using a far less toxic process.
Its plentiful-and renewable-seed provides more than enough natural, non-toxic oil to eliminate the need for any other energy source for all of mankind’s foreseeable future. It is the solution to all of humanity’s problems. It is the single greatest hope for the starving of mankind. It can be made into home building materials and turned into fabrics that produce clothes that are almost indestructible, More….

Independent on Sunday and cannabis - on it goes
Transform-drugs.blogspot.com
April 17th 2007

In March we posted two detailed blogs responding to the Independent on Sunday’s two-week long canna-pology and retraction of support for their 1997 campaign for decriminalisation of the drug in 1997. How the Independent on Sunday got it horribly wrong on Cannabis

The Independent’s born-again war on drugs: Round Two

To summarise: the basis for their new stance was the new evidence they ‘revealed’ about the potency cannabis today, and its terrible toll on the mental health of Britain’s youth. The blogs highlighted how the claims they were making were bad science: exageration, cherry picking and good old fashioned lazy sensationalist journalism, and also how there new editorial position totally misunderstood the issue, confusing the debate around drug harms with the debate around policy responses to those harms. (look, just read them).
The IOS has argued itself into a corner. After making such a big deal of retracting their support for progressive law reform there is no way they can back down now without considerable embarrassment and humiliation (it would certainly prove a poser for the headline writers next time around, although they could arguably reuse the first ‘Cannabis: an apology’ ). On the other hand, to support their case for prohibition – on the basis of the dangers of cannabis – they now feel obliged to produce a constant stream of shock-horror cannabis coverage which, given that they have very clearly nailed their franken-pot colours to the mast, will inevitably be un-bothered by scientific or journalistic objectivity. And, surprise, surprise, this is exactly what we have seen over the last three of weeks. Here’s a quick guided tour:
The April 1 edition saw a front page teaser apparently borrowed from their tabloid colleagues, Full Comment….

“homespun cottage industry” News2020.com March 3rd 2007 Vietnamese organised crime is behind a sudden explosion of cannabis cultivation in Scotland in the past year, with more than 40 factories producing £5 million of the drug in the past nine months. Graeme Pearson, head of the Scottish Crime and Drug Enforcement Agency (SCDEA), will today tell a drugs conference that cannabis cultivation in Scotland has gone from a “homespun cottage industry” to mass production lines overseen by Far Eastern “Mr Bigs”. A network of Vietnamese gangs, responsible for mass cannabis production in North America and the south of England, is understood to have recruited members of the Chinese community in Scotland to set up dozens of factories across the country in recent months. A big rise in cannabis cultivation in parts of England has already been witnessed in recent months, with the proceeds reinvested in other aspects of organised crime, including heroin, cocaine and firearms. Last week police disclosed the results of Operation League, a major cannabis-production crackdown, mainly in the west of Scotland, which has seen about 20 factories shut down. Police made several arrests during the operation, including Vietnamese and Chinese nationals, along with Scots, Full Crime….

Next Page »

News2020.com